{"filing":{"accession_number":"0001213900-26-082514","cik":"0001839285","ticker":"HCTI","company_name":"Healthcare Triangle, Inc.","form":"8-K","filing_date":"2026-07-29","report_date":"2026-07-28","primary_document":"ea0299551-8k_healthcare.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1839285/000121390026082514/ea0299551-8k_healthcare.htm"},"events":[{"id":21389,"run_id":19290,"accession_number":"0001213900-26-082514","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Healthcare Triangle issued 12,546,540 unregistered shares of common stock on July 28, 2026, comprising 9,718,373 shares to Teyame AI LLC entities and 2,828,167 shares to SecureKloud Technologies Ltd. counterparties, both in reliance on Section 4(a)(2) and Regulation D exemptions. This represents a substantial dilutive issuance that increased outstanding shares from approximately 2.1 million to 14.6 million—a material capital event disclosed under Item 3.02 and explicitly highlighted in the press release as strengthening the company's Nasdaq listing compliance position.","company_name":"Healthcare Triangle, Inc.","ticker":"HCTI","filing_date":"2026-07-29","form":"8-K","submitted_at":null,"items":[{"id":21018,"accession_number":"0001213900-26-082514","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Healthcare Triangle issued 12,546,540 unregistered shares of common stock on July 28, 2026, comprising 9,718,373 shares to Teyame AI LLC entities and 2,828,167 shares to SecureKloud Technologies Ltd. counterparties, both in reliance on Section 4(a)(2) and Regulation D exemptions. This represents a substantial dilutive issuance that increased outstanding shares from approximately 2.1 million to 14.6 million—a material capital event disclosed under Item 3.02 and explicitly highlighted in the press release as strengthening the company's Nasdaq listing compliance position.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T11:11:37.510675+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":21018,"accession_number":"0001213900-26-082514","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Healthcare Triangle issued 12,546,540 unregistered shares of common stock on July 28, 2026, comprising 9,718,373 shares to Teyame AI LLC entities and 2,828,167 shares to SecureKloud Technologies Ltd. counterparties, both in reliance on Section 4(a)(2) and Regulation D exemptions. This represents a substantial dilutive issuance that increased outstanding shares from approximately 2.1 million to 14.6 million—a material capital event disclosed under Item 3.02 and explicitly highlighted in the press release as strengthening the company's Nasdaq listing compliance position.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T11:11:37.510675+00:00","company_name":"Healthcare Triangle, Inc.","ticker":"HCTI","filing_date":"2026-07-29"}]}